148 related articles for article (PubMed ID: 34375194)
1. Development of fluorinated and methoxylated benzothiazole derivatives as highly potent and selective cannabinoid CB
Aly MW; Ludwig FA; Deuther-Conrad W; Brust P; Abadi AH; Moldovan RP; Osman NA
Bioorg Chem; 2021 Sep; 114():105191. PubMed ID: 34375194
[TBL] [Abstract][Full Text] [Related]
2. Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB
Heimann D; Börgel F; de Vries H; Patberg M; Jan-Smith E; Frehland B; Schepmann D; Heitman LH; Wünsch B
Eur J Med Chem; 2018 Feb; 146():409-422. PubMed ID: 29407967
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory properties.
Ghonim AE; Ligresti A; Rabbito A; Mahmoud AM; Di Marzo V; Osman NA; Abadi AH
Eur J Med Chem; 2019 Oct; 180():154-170. PubMed ID: 31302448
[TBL] [Abstract][Full Text] [Related]
4. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
[TBL] [Abstract][Full Text] [Related]
5. Identification and Preclinical Development of a 2,5,6-Trisubstituted Fluorinated Pyridine Derivative as a Radioligand for the Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Gobbi L; Kretz J; Ullmer C; Brink A; Honer M; Woltering TJ; Muri D; Iding H; Bürkler M; Binder M; Bartelmus C; Knuesel I; Pacher P; Herde AM; Spinelli F; Ahmed H; Atz K; Keller C; Weber M; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2020 Sep; 63(18):10287-10306. PubMed ID: 32787079
[TBL] [Abstract][Full Text] [Related]
6. Structure-Activity Relationship Studies of Pyridine-Based Ligands and Identification of a Fluorinated Derivative for Positron Emission Tomography Imaging of Cannabinoid Type 2 Receptors.
Haider A; Kretz J; Gobbi L; Ahmed H; Atz K; Bürkler M; Bartelmus C; Fingerle J; Guba W; Ullmer C; Honer M; Knuesel I; Weber M; Brink A; Herde AM; Keller C; Schibli R; Mu L; Grether U; Ametamey SM
J Med Chem; 2019 Dec; 62(24):11165-11181. PubMed ID: 31751140
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.
Osman NA; Ligresti A; Klein CD; Allarà M; Rabbito A; Di Marzo V; Abouzid KA; Abadi AH
Eur J Med Chem; 2016 Oct; 122():619-634. PubMed ID: 27448919
[TBL] [Abstract][Full Text] [Related]
8. Development of Highly Affine and Selective Fluorinated Cannabinoid Type 2 Receptor Ligands.
Moldovan RP; Hausmann K; Deuther-Conrad W; Brust P
ACS Med Chem Lett; 2017 May; 8(5):566-571. PubMed ID: 28523112
[TBL] [Abstract][Full Text] [Related]
9. Fluorinated cannabinoid CB2 receptor ligands: synthesis and in vitro binding characteristics of 2-oxoquinoline derivatives.
Turkman N; Shavrin A; Ivanov RA; Rabinovich B; Volgin A; Gelovani JG; Alauddin MM
Bioorg Med Chem; 2011 Sep; 19(18):5698-707. PubMed ID: 21872477
[TBL] [Abstract][Full Text] [Related]
10. Optimization of pharmacokinetic properties by modification of a carbazole-based cannabinoid receptor subtype 2 (CB
Heimann D; Börgel F; de Vries H; Bachmann K; Rose VE; Frehland B; Schepmann D; Heitman LH; Wünsch B
Eur J Med Chem; 2018 Jan; 143():1436-1447. PubMed ID: 29126730
[TBL] [Abstract][Full Text] [Related]
11. Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands.
Pinna G; Curzu MM; Dore A; Lazzari P; Ruiu S; Pau A; Murineddu G; Pinna GA
Eur J Med Chem; 2014 Oct; 85():747-57. PubMed ID: 25134064
[TBL] [Abstract][Full Text] [Related]
12. Mastering tricyclic ring systems for desirable functional cannabinoid activity.
Petrov RR; Knight L; Chen SR; Wager-Miller J; McDaniel SW; Diaz F; Barth F; Pan HL; Mackie K; Cavasotto CN; Diaz P
Eur J Med Chem; 2013 Nov; 69():881-907. PubMed ID: 24125850
[TBL] [Abstract][Full Text] [Related]
13. Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties.
Deiana V; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Asproni B; Cichero E; Fossa P; Muñoz E; Deligia F; Murineddu G; García-Arencibia M; Pinna GA
Eur J Med Chem; 2016 Apr; 112():66-80. PubMed ID: 26890113
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
[TBL] [Abstract][Full Text] [Related]
15. Investigations on the 4-quinolone-3-carboxylic acid motif. 6. Synthesis and pharmacological evaluation of 7-substituted quinolone-3-carboxamide derivatives as high affinity ligands for cannabinoid receptors.
Pasquini S; De Rosa M; Ligresti A; Mugnaini C; Brizzi A; Caradonna NP; Cascio MG; Bolognini D; Pertwee RG; Di Marzo V; Corelli F
Eur J Med Chem; 2012 Dec; 58():30-43. PubMed ID: 23085772
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of (Z)-2-((1-benzyl-1H-indol-3-yl)methylene)-quinuclidin-3-one analogues as novel, high affinity ligands for CB1 and CB2 cannabinoid receptors.
Madadi NR; Penthala NR; Brents LK; Ford BM; Prather PL; Crooks PA
Bioorg Med Chem Lett; 2013 Apr; 23(7):2019-21. PubMed ID: 23466226
[TBL] [Abstract][Full Text] [Related]
17. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
19. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
[TBL] [Abstract][Full Text] [Related]
20. Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-
Mugnaini C; Kostrzewa M; Casini M; Kumar P; Catallo V; Allarà M; Guastaferro L; Brizzi A; Paolino M; Tafi A; Kapatais C; Giorgi G; Vacondio F; Mor M; Corelli F; Ligresti A
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
